Quest to acquire Lewisville, Texas-based Med Fusion and Clear Point to create a base in the southwestern United States for providing precision medicine diagnostics to aid cancer treatment and care

Data scientists form Microsoft have donated a newly developed research tool to Seattle Children’s Research Institute to advance research into sudden infant death syndrome (SIDS). The tool will also be available to researchers around the globe.

Surefire Medical, Inc., the developer of site-specific delivery devices for the Interventional Oncology market, announced today results from a retrospective analysis of 85 bridge-to-transplant liver cancer patients treated with transarterial chemoembolization (DEB-TACE) that shows therapy delivery with the Surefire Infusion System was associated with an 80 percent complete response in one treatment versus 52 percent with a standard endhole microcatheter. In addition, the analysis shows a statistically significant lower recurrence rate of liver cancer at one month of 13 percent using Surefire technology versus 52 percent recurrence with a standard microcatheter.

 Royal Philips (NYSE: PHG AEX: PHIA) today announced the relaunch of its innovative Pioneer Plus catheter, the first and only re-entry device with intravascular ultrasound (IVUS) capabilities and needle deployment designed to assist arterial vessel intervention. IVUS captures images of vessels in the peripheral vascular system from inside the artery, allowing physicians to identify a targeted area and place a catheter in a specific location and to help guide the treatment partially or fully blocked arteries. 

A recent survey shows an increasing number of adults were enrolled in health plans with deductibles above $1,300 for individual plans and $2,600 for family coverage in 2016 as more employers turn to plans with higher out-of-pocket costs.

Smartphone applications are good for counting steps—but not treating back pain. In a study, published in Best Practice & Research: Clinical Rheumatology, researchers from the University of Sydney evaluated apps in reducing back pain.

SAN FRANCISCO--(BUSINESS WIRE)--Kenzen, an innovator of wearables for precision health, today announced it has raised $5 million from multiple investors to further development, support and market positioning of its ECHO Smart Patch wearable technology. Kenzen’s smart wearable patch continuously uses non-invasive sweat analysis to measure vital signs and motion sensors to predict and prevent avoidable injuries and illness.

Detroit’s Henry Ford Health System has broken ground on a $155 million expansion of its cancer institute, to be named the Brigette Harris Cancer Pavilion.